Prescribed List reforms

Have your say

We encouraged stakeholders to participate in consultations about the reforms. This helped us make sure the Prescribed List remains strong and fit for purpose.

Learn more about the consultations for the reforms.

Reforms

The Prescribed List reforms finished in June 2025.  Read more about the reforms objectives and achievements.

• Modernising the application process
  Learn about the new advisory committee, expert clinical advisory groups and listing pathways.
• Modernising Part B (human tissue products) of the Prescribed List
  Learn about the proposed reforms to Part B of the Prescribed List.
• Reducing the public and private sector price gap
  Learn about previous and future reductions to Prescribed List benefits, and when they will be implemented.
• Benefit reductions for Cardiac Implantable Electronic Devices (CIEDs)
  Learn about how we are reducing Prescribed List benefits for CIEDs.
• General use items (GUI)
  Learn about General Use Items on the Prescribed List.
• Changes in legislation
  Learn about legislation changes to the Private Health Insurance Act 2007 and related legislation.
• Improving compliance and assurance
  Learn about the proposed compliance and assurance measures to safeguard the Prescribed List.
• Moving applications to the Health Products Portal
  Learn about the new application portal and important dates.

Contact